Home Latest News Indian-Origin Scientist Fears UK’s COVID-19 Strategy Took Wrong Path
Latest News

Indian-Origin Scientist Fears UK’s COVID-19 Strategy Took Wrong Path

Share
Share

Amidst spike in coronavirus cases and raising concern over less COVID-19 testing, a leading Indian-origin scientist and public health expert has expressed fears that the UK’s strategy to not focus on greater testing and containment in the initial stages of the coronavirus pandemic may have been the “wrong path” to take in the country’s efforts to control the outbreak.

Professor of Global Public Health at the University of Edinburgh Devi Sridhar said planning for large-scale testing for the deadly virus was taken off the table early on as the government based its strategy on an Imperial College of London model, which seemed to rely on so-called “herd immunity” for a large enough section of the population to contract COVID-19 and build natural immunity over time.

“I fear that Imperial perspective (in Lancet) resulted in the UK giving up on containment too early and assuming everyone will get it,” Prof. Sridhar said on Twitter.

“Planning and preparing for unprecedented testing and using big data/apps for tracing were taken off the table. In my view, we went down the wrong path,” said Sridhar, who is supporting the World Health Organisation (WHO) on policy and governance through the pandemic.

The expert, from Edinburgh University’s Usher Institute – College of Medicine and Veterinary Medicine, warned that the UK could be in for an endless cycle of lockdown and release if the assumption being worked on is that everyone at some stage is likely to be hit by the deadly virus, which has claimed 1,789 lives in the country.

“If assumption is everyone will get it, then UK will indeed be in an endless cycle of lockdown/release as the government turns on/off tap of spread to let virus filter through the population and attempt to keep ICU need within capacity. All while most vulnerable attempt to self-isolate,” she said.

The 35-year-old expert, who has been working alongside colleagues at her university to help people better understand the global challenge and the science behind the virus, has a research focus on the effectiveness of public health interventions.

During a session alongside former US President Bill Clinton’s daughter Chelsea at the UK’s Hay Festival in 2018, she had made references to the “interconnected” aspect of global health challenges.

“I forgot I had said this but in 2018 I gave the example of someone being infected in China by an animal, getting on a plane to the UK and having it be a challenge here – all to illustrate why health challenges are interconnected,” she recalls.

The coronavirus epicentre was in China’s Wuhan city and has since spread around the world, with the US overtaking the Chinese death toll this week and the global figures crossing 40,000.

“What could we have done different or better in the public health community to prevent the spread? That will keep many of us awake for nights ahead,” notes Sridhar, after a 13-year-old boy became the UK’s youngest victim of COVID-19 this week.

The UK government has admitted the urgent need to ramp up testing, with health minister Matt Hancock calling on hospitals to go further and test as many National Health Service (NHS) staff as they can.

British Prime Minister Boris Johnson and Hancock – who are both self-isolating after testing positive for COVID-19 – are said to be working with companies worldwide to get the materials needed to build up testing capacity.

“It’s been well over two weeks since the government said it was going to roll out priority testing for healthcare staff. But many doctors still have no idea about where or how they can get tested,” said Chaand Nagpaul, the Indian-origin chair of the British Medical Association (BMA).

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Latest News

Nipah Virus in India: What You Should Know and How to Stay Safe

Nipah virus (NiV) is a rare but highly dangerous zoonotic virus that can be transmitted from animals to humans and, in some cases,...

Latest News

How Seasonal Flu Symptoms Are Changing in 2026—and What It Means for You

Seasonal influenza, commonly known as the flu, affects millions of people worldwide every year, and 2026 has already shown changes in how the...

WHO
Press Release

WHO South-East Asia Regional Office building inaugurated

The newly constructed building of the World Health Organization South-East Asia Regional Office in New Delhi, was today inaugurated by the Honourable Prime...

Air Pollution
Health News

Delhi Chokes Under Toxic Air: Schools Shut, Offices Go Work From Home — How to Stay Safe

New Delhi, 23 December, 2025: Delhi once again finds itself gasping for breath as air pollution levels surge to hazardous levels, pushing authorities...

Colorectal cancer
Latest News

Cervical Cancer Awareness Month 2026: Screening Tips Every Woman Should Know

Cervical cancer is one of the most preventable forms of cancer, yet it remains a leading cause of cancer-related deaths among women globally....

Section title

Related Articles
Latest News

International Epilepsy Day 2026: Why Early Diagnosis and Treatment Can Change Lives for Millions in India

Every year, International Epilepsy Day serves as a crucial reminder of the...

Latest News

Broken Heart Syndrome Is Real: Doctor Explains Why Emotional Stress Can Trigger Heart Attacks

When we hear the phrase “broken heart,” most of us think of...

COVID
Latest News

Long COVID May Be Triggering Alzheimer’s-Like Changes in the Brain: New Study

A new study suggests that Long COVID—the lingering post-infection condition experienced by...

Cancer
Latest News

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

Cancer treatment has evolved rapidly over the past few decades, offering patients...

×